Retrieve available abstracts of 62 articles: HTML format
Single Articles
June 2025
LIU S, Pan Q, Xu H, Luo Y, et al Activation of fibroblast in intestinal Behcet's disease shown by 68Ga-FAPI-04
PET/CT.
Nuklearmedizin. 2025;64:231-233. PubMed
YANG H, Zhang Y, Guan Z, Li C, et al The diagnostic performance of an [18F]FDG PET/CT algorithm for preoperative
evaluation of extrahepatic cholangiocarcinoma: a retrospective study.
Nuklearmedizin. 2025;64:205-214. PubMedAbstract available
DROPMANN JA, Kleespies A, Fuerst H, Kremer M, et al Importance of oxyphil cells for 99mTc-sestamibi uptake in primary
hyperparathyroidism: a retrospective observational study.
Nuklearmedizin. 2025;64:215-224. PubMedAbstract available
May 2025
WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
Nuklearmedizin. 2025 May 20. doi: 10.1055/a-2604-5823. PubMed
BAEHR M, Dietrich I, Liepe K [99mTc]Tc-PSMA SPECT/CT is a promising tool in the staging of renal cell
carcinoma.
Nuklearmedizin. 2025 May 12. doi: 10.1055/a-2578-7222. PubMed
April 2025
BUCHERT R, Drzezga A, Schreckenberger M, Langen KJ, et al The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st
Survey on Nuclear Neuroimaging in Germany in 2023.
Nuklearmedizin. 2025 Apr 15. doi: 10.1055/a-2566-1487. PubMedAbstract available
LUNA R, Laheru DA, Shin EJ, Lossos C, et al Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT.
Nuklearmedizin. 2025;64:177-179. PubMed
WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
Nuklearmedizin. 2025;64:156-162. PubMedAbstract available
ORBOM A, Evans-Axelsson S, Jansson B, Vilhelmsson Timmermand O, et al Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1
targeting monoclonal antibody R6.5 in a prostate cancer mouse model.
Nuklearmedizin. 2025;64:163-169. PubMedAbstract available
EBRAHIMIFARD A, Rajabi H, Geramifar P, Luster M, et al The impact of the xSPECT reconstruction algorithms on the recovery coefficients
value for small tumors: a phantom study with 177Lu.
Nuklearmedizin. 2025;64:132-140. PubMedAbstract available
VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al Comparison of 2D and 3D lung lobe quantification with Ventilation/Perfusion
Ratio.
Nuklearmedizin. 2025;64:142-149. PubMedAbstract available
March 2025
BAUDE JK, Mottaghy FM, Derlin T, Fischer A, et al PSMA - Targeted Clinical Molecular Imaging of Atherosclerosis: Correlation with
Cardiovascular Risk Factors.
Nuklearmedizin. 2025;64:13-21. PubMedAbstract available
January 2025
VURAL TOPUZ O, Bagbudar S, Aksu A, Soylemez Akkurt T, et al Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict
tumor-infiltrating lymphocyte values in patients with primary breast cancer.
Nuklearmedizin. 2025 Jan 28. doi: 10.1055/a-2512-8212. PubMedAbstract available
December 2024
CEGLA P, Currie G, Wroblewska JP, Kazmierska J, et al [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status
in Head and Neck Cancer.
Nuklearmedizin. 2024 Dec 4. doi: 10.1055/a-2365-7808. PubMedAbstract available
GRUNERT M, Schenke SA, Konrad A, Schutze C, et al Thyroid scintigraphy: establishing a clinically useful normal range for 99mTc
pertechnetate uptake.
Nuklearmedizin. 2024;63:337-346. PubMedAbstract available
November 2024
RUGGIERO C, Maracaja D, Rowe SP Langerhans Cell Histiocytosis-Associated Vertebra Plana on FDG PET.
Nuklearmedizin. 2024 Nov 27. doi: 10.1055/a-2438-7469. PubMed
ZHAO G, Huang Z A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor on 18F-FDG PET/CT.
Nuklearmedizin. 2024 Nov 20. doi: 10.1055/a-2383-2527. PubMedAbstract available
SCHULZ L, Funk GC, Kirchbacher K, Egger E, et al Comparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base
to upper abdomen for primary staging of lung cancer - a retrospective explorative
analysis.
Nuklearmedizin. 2024 Nov 11. doi: 10.1055/a-2438-7278. PubMedAbstract available
October 2024
VOLTIN CA, Spreckelmeyer S, Essler M, Holzgreve A, et al Toward the future of nuclear medicine: How young professionals are getting
involved and what plans they have.
Nuklearmedizin. 2024;63:284-286. PubMed
VOGEL J, Haghghi S, Herkula C, Petersen M, et al Interobserver Agreement of visual and semi-quantitative methods in
99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging for risk stratification of
hypofunctional thyroid nodules.
Nuklearmedizin. 2024;63:294-299. PubMedAbstract available
ZEIDLER R, Tiepolt S, Hesse S, Sabri O, et al Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky
case of an extensive, displacing growing retroperitoneal liposarcoma.
Nuklearmedizin. 2024;63:306-307. PubMed
September 2024
JAFARI E, Manafi-Farid R, Ahmadzadehfar H, Salek F, et al Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived
Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free
Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
Undergoing [177Lu]Lu
Nuklearmedizin. 2024 Sep 3. doi: 10.1055/a-2365-8113. PubMedAbstract available
August 2024
RAHBAR NIKOUKAR L, Seifert R, Ventura D, Schindler P, et al Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in
mCRPC patients treated with PSMA radioligands.
Nuklearmedizin. 2024 Aug 29. doi: 10.1055/a-2383-2468. PubMedAbstract available
VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al Computational Decision Support for PE Diagnosis based on Ventilation Perfusion
Ratio.
Nuklearmedizin. 2024;63:259-266. PubMedAbstract available
July 2024
LANDAU F, Hermann S, Schelhaas S, Schafers M, et al 18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial
imaging: precursor synthesis, radiolabelling and in vitro evaluation.
Nuklearmedizin. 2024 Jul 31. doi: 10.1055/a-2365-8054. PubMedAbstract available
BREDENSTEINER L, Ventura D, Rassek P, Schafers M, et al Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the
detection of bone metastases in prostate cancer patients.
Nuklearmedizin. 2024 Jul 12. doi: 10.1055/a-2344-6825. PubMedAbstract available
May 2024
SCHMIDT M, Hohberg M, Felcht M, Kuhn T, et al [Nuclear medicine procedure guideline for sentinel lymph node localization].
Nuklearmedizin. 2024 May 24. doi: 10.1055/a-2319-8306. PubMedAbstract available
HEIDEMANNS S, Trautmann S, Weidt D, Hellwig D, et al Update of the competence-based catalog of learning objectives in nuclear medicine
for the study of human medicine in Germany.
Nuklearmedizin. 2024 May 22. doi: 10.1055/a-2319-7549. PubMedAbstract available
April 2024
WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric
antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417. PubMedAbstract available
BOCK F, Frerker B, Schubert L, Rennau H, et al Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer
patients.
Nuklearmedizin. 2024 Apr 5. doi: 10.1055/a-2284-0593. PubMedAbstract available
SAEED S, Dimopoulos I, Begum N, Kroger JR, et al [Not Available].
Nuklearmedizin. 2024;63:78-80. PubMed
WERNER R, Haug A, Buske C, Heidegger S, et al CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Nuklearmedizin. 2024;63:57-61. PubMedAbstract available
March 2024
GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing
pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
Nuklearmedizin. 2024 Mar 25. doi: 10.1055/a-2286-9571. PubMed
USLU H, Sahin D, Tatoglu MT, Ibisoglu E, et al Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT.
Nuklearmedizin. 2024 Mar 14. doi: 10.1055/a-2273-2350. PubMed
GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic
leiomyosarcoma and papillary thyroid carcinoma.
Nuklearmedizin. 2024 Mar 11. doi: 10.1055/a-2273-2447. PubMed
LIU Y, Tang W, Huang Z Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic
Osteosarcoma.
Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035. PubMed
February 2024
CHEN M, Liu Y Correction: 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2265-4049. PubMed
AYDAR S, Knobl H, Burchert W, Lindner O, et al Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus
myocardial perfusion SPECT in patients with suspected or known coronary heart
disease.
Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2263-2322. PubMedAbstract available
CHEN M, Liu Y 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
Nuklearmedizin. 2024 Feb 7. doi: 10.1055/a-2237-8775. PubMed
UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients
with Primary Cervical Cancer.
Nuklearmedizin. 2024;63:34-42. PubMedAbstract available
FISCHER M, Schneider-Eicke J Nonosseous bone seeking tracer focal uptake in the conventional scintigraphy.
Nuklearmedizin. 2024;63:45-47. PubMed
DIETLEIN M, Grunwald F, Schmidt M, Kreissl MC, et al [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No.
031-003)].
Nuklearmedizin. 2024;63:8-20. PubMedAbstract available
January 2024
FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al [Evaluation of risk analysis in treatment with unsealed radioactive substances in
nuclear medicine].
Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639. PubMed
MAMAN A Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare
Case Study and Clinical Considerations.
Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186. PubMed
NOURBAKHSH S, Salehi Y, Farzanehfar S, Ghaletaki R, et al FAPI PET/CT provides higher uptake and better target to back ground in recurrent
and metastatic tumors of patients with Iodine refractory papillary thyroid cancer
compared with FDG PET CT.
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2185-7746. PubMedAbstract available
ARSLANTAS E, Aycicek A, Esen Akkas B, Tahtakesen Gucer TN, et al The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid
Tumors.
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9441. PubMedAbstract available
VURAL TOPUZ O, Bagbudar S Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer:
A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673. PubMed
SANTO G, Di Santo G, Zelger B, Virgolini I, et al Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a
mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220. PubMed
December 2023
SERFLING SE, Buck A, Rowe SP, Higuchi T, et al Red Bull PET/CT.
Nuklearmedizin. 2023 Dec 22. doi: 10.1055/a-2195-0138. PubMedAbstract available
ROGASCH JMM, Shi K, Kersting D, Seifert R, et al Methodological evaluation of original articles on radiomics and machine learning
for outcome prediction based on positron emission tomography (PET).
Nuklearmedizin. 2023;62:361-369. PubMedAbstract available
WENDLER T, Kreissl MC, Schemmer B, Rogasch JMM, et al Artificial Intelligence-powered automatic volume calculation in medical images -
available tools, performance and challenges for nuclear medicine.
Nuklearmedizin. 2023;62:343-353. PubMedAbstract available
HELLWIG D, Hellwig NC, Boehner S, Fuchs T, et al Artificial Intelligence and Deep Learning for Advancing PET Image Reconstruction:
State-of-the-Art and Future Directions.
Nuklearmedizin. 2023;62:334-342. PubMedAbstract available
MIEDERER I, Rogasch JMM, Wendler T AI in Nuclear Medicine - a review of the current situation.
Nuklearmedizin. 2023;62:332-333. PubMed
November 2023
LOHMANN P, Bundschuh RA, Miederer I, Mottaghy FM, et al Clinical Applications of Radiomics in Nuclear Medicine.
Nuklearmedizin. 2023 Nov 7. doi: 10.1055/a-2191-3271. PubMedAbstract available
October 2023
FUCHS T, Kaiser L, Muller D, Papp L, et al Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and
Associated Clinical Data.
Nuklearmedizin. 2023 Oct 31. doi: 10.1055/a-2187-5701. PubMedAbstract available
RASSEK P, Bobe S, Kies P, Roll W, et al The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET
positive thyroid metastasis from colorectal cancer.
Nuklearmedizin. 2023 Oct 23. doi: 10.1055/a-2178-6908. PubMed
BROSCH-LENZ JF, Delker A, Schmidt F, Tran-Gia J, et al On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical
Therapies.
Nuklearmedizin. 2023 Oct 12. doi: 10.1055/a-2179-6872. PubMedAbstract available
MOON H, Ku EJ, Kim C Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CT.
Nuklearmedizin. 2023;62:294-295. PubMed
KUSTNER T, Hepp T, Seith F Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and
Opportunities.
Nuklearmedizin. 2023;62:306-313. PubMedAbstract available
September 2023
DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify
prognostic groups in low-risk NSCLC.
Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130. PubMedAbstract available
MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al The Medical Informatics Initiative and the Network University Medicine -
Perspectives for Nuclear Medicine.
Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642. PubMedAbstract available
August 2023
FROHLICH M, Schmalzing M, Buck A, Bley TA, et al PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free
Survival in Patients with Giant Cell Arteritis.
Nuklearmedizin. 2023;62:229-234. PubMedAbstract available